This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Bristol-Myers Squibb Company
Drug Names(s): BMS986177, BMS 986177
Description: BMS-986177 appears to be a factor XIa inhibitor, based on BMY's pipeline and information in early clinical trials.
Additional information available to subscribers only: